News/Events

Stay up to date with our latest news and events.

Antibody, IgG (immunoglobulin), antibody labeling, monoclonal antibodies

Advance Your Research with High-quality Monoclonal Antibody Labeling

3/28/2017

High-quality labeled antibodies are crucial for many research applications including Western blotting, ELISA, immunofluorescence, immunohistochemistry, and flow cytometry. Specialized conjugates are not always commercially available but can be custom produced to your specifications at Proteos.

Tags: Antibody labeling, Antibody Production, Monoclonal Antibodies

Insect Cell Expression

Ensure Reproducible Insect Cell Expression with Accurate Baculovirus Titers

1/23/2017

An accurate baculovirus titer is essential for optimal insect cell expression and reproducibility. Proteos offers a rapid, economical flow cytometry assay for titer determination. 

Tags: baculovirus expression, insect cell expression, services

Alpha-synuclein Research Tools poster co-authored by Lindsey Gottler, PhD., Proteos’ Director of Protein Purification

12/7/2016

The Michael J. Fox Foundation's Strategy to Generate, Characterize, and Distribute Preclinical Alpha-Synuclein Research Tools for Molecular Biology presented at Neuroscience 2016.

Tags: Alpha-synuclein, MJFF, Parkinson's

Neuroscience 2016 – Michael J. Fox Foundation Poster Presentation - Research tools for Parkinson’s disease

11/11/2016

The Michael J. Fox Foundation will be presenting a poster at this year’s conference describing the research tools program:  The Michael J. Fox Foundation's Strategy to Generate, Characterize, and Distribute Preclinical Alpha-Synuclein Research Tools for Molecular Biology

Tags: MJFF, neuroscience, Parkinson's

Neuroscience 2016 – November 12-16 – San Diego, CA

11/4/2016

Proteos will be exhibiting at Neuroscience 2016.  Please stop by booth 4304 to meet us and learn why we are an industry leader in the production of recombinant proteins and antibodies.

Tags: neuroscience, Parkinson's

Neuroscience 2016

Proteos, Inc. to Attend Neuroscience 2016, November 12 to 16 in San Diego

8/8/2016

Celebrating over 30,000 attendees from over 80 countries, the Society for Neuroscience's (SfN) annual meeting is the world's premier destination for anyone seeking ideas and tools related to the field. With members able to view more than 15,000 abstracts, explore countless exhibits and network with other professionals in the field, the meeting aims to assist neuroscience professionals at all stages of their careers.

Tags: neuroscience

Michael J. Fox Foundation

Michael J. Fox Foundation Announces Library of Available Recombinant DJ-1 Proteins in Collaboration with Proteos

8/5/2016

The Michael J. Fox Foundation (MJFF) first goal is to propel breakthroughs that Parkinson's sufferers can immediately feel in their day to day lives. The foundation realizes the importance of protein reagents in many applications related to treating Parkinson's disease. MJFF has partnered with Proteos who provides them with the best quality reagents to support research of Parkinson's disease.

Tags: DJ-1, MJFF

Proteos to attend the 5th Annual Grand Challenges in Parkinson's Disease Scienti

Upcoming Event - Proteos to attend the 5th Annual Grand Challenges in Parkinson's Disease Scientific Symposium

7/1/2016

Proteos will be attending the 5th annual Grand Challenges in Parkinson’s Disease scientific symposium at the Van Andel Research Institute in Grand Rapids, MI from September 26-27, 2016.  Please stop by our booth to learn more about Proteos.

Tags: Parkinson's, Van Andel Research Institute

New Alpha-synuclein Filament-specific Antibody

1/26/2016

Now available from the MJFF Research Tools Program is a conformation-specific rabbit monoclonal antibody raised against filament alpha-synuclein, which recognizes both oligomeric and filamentous alpha-synuclein. This project was done in partnership with Proteos, Inc.; Abcam; and Aarhus University.

New Alpha-synuclein Proteins Available

Tags: Alpha-synuclein, MJFF

Commercial Launch of Human Alpha-synuclein Proteins

10/30/2015

MJFF announced the commercial launch of human alpha-synuclein proteins including monomeric and filament versions, as well as protocols and specially formulated monomeric alpha-synuclein to generate pre-formed fibrils. This project was in partnership with Proteos, Inc., and the proteins were validated by the Jensen and Luk laboratories at Aarhus University and the University of Pennsylvania, respectively.

Tags: Alpha-synuclein, MJFF

Customize This